M. Zottmann

Papers

Total Citations

H-Index

About

M. Zottmann is a researcher advancing precision oncology through sensor-based screening technologies. Their most-cited work, "Sensor-based cell and tissue screening for personalized cancer chemotherapy" (2012), has garnered 24 citations, establishing a foundation for integrating biosensors into individualized treatment planning. This contribution focuses on developing platforms that assess patient-derived cells and tissues in real time, enabling more effective chemotherapy selection by capturing dynamic cellular responses. Zottmann’s research bridges bioengineering and clinical oncology, aiming to replace trial-and-error approaches with data-driven, patient-specific therapies. By leveraging microfluidic and sensor technologies, their work supports the broader goal of reducing adverse drug reactions and improving outcomes in cancer care. Though early in impact, this study has influenced subsequent investigations into high-throughput drug testing and tissue-on-a-chip models. Zottmann’s dedication to merging engineering principles with medical needs highlights a commitment to translating laboratory innovations into practical, patient-centered solutions—a vital step toward the future of personalized medicine.